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Abstract
Background: Adequate reporting of ethics-related research methods promotes convergence on best ethics
practices. In physical therapy, studies on ethics reporting are limited to few aspects, and none focuses on stroke
research. Our objectives were to investigate the reporting of multiple ethics-related features and its variation over
time, and the characteristics of the studies associated with ethics reporting in Randomized Controlled Trials (RCTs)
of physical therapy interventions after stroke.
Methods: A random sample of RCTs published in the years 2004, 2009 and 2014, was extracted from the PubMed
database, regardless of the publishing journal. For each trial we investigated year of publication, trial registration,
sample size, stroke subtype, phase of the disease, setting, interventions and dosing, outcome measures, outcome of
the study, PEDro score and 5-year impact factor of the publishing journal. Reporting of ethics-related issues was
analyzed. Differences between groups were examined. Multiple regression was used to evaluate the relationship
between ethics-related issues reporting and some studies’ characteristics.
Results: Eighty studies were reviewed. Groups differed in the proportion of registered trials (p = .009), 5-year impact
factor (p = .011), assessment of cognitive capacity (p = .049), declaration about conflict of interest (p < .001), and
number of ethics-related issues reported (p = .009). The proportion of issues reported ranged from 92.5% (consent
obtaining) to 0% (eventual follow up care). Post-hoc comparisons showed significantly greater reporting of ethics
issues in trials published in the year 2014 compared to 2004 (p = .014, 95%CI = 0.40/4.26). Year of publication and
PEDro score were significant predictors of adequate reporting.
Conclusions: Authors, editors, and reviewers should be more rigorous and demanding about the reporting of
ethic-related methods in randomized controlled trials of physical therapy interventions after stroke.
Keywords: Ethics reporting, Physical therapy, Randomized controlled trials, Stroke
Background
The importance of ethics in clinical research has been
well-established for many decades [1]. A growing atten-
tion is given to determine the best ethical practices for
conducting observational and experimental studies [2].
Methodological quality, approval by a research ethics
committee, and obtaining informed consent from partic-
ipants are the main ethical issues in research with hu-
man beings [3].
Randomized controlled trial (RCT), systematic review
and meta-analysis of RCTs are considered reliable re-
search designs, able to evaluate the effectiveness of an
intervention [1]. The design of a clinical trial implies ad-
herence to challenging and multifaceted ethical and
methodological standards that must integrate each other
[4]; Ashton et al. in their taxonomy indeed identified five
major categories, with over 5900 possible standards [4].
Differences among research topics and study designs
may add further variability in ethical requirements
[5–8]. Research conducted with little methodological
rigor does not lead to knowledge or benefit, and ex-
poses participants to unnecessary burden or harm [9].
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Thus methodological and ethical requirements of a
study have a symbiotic relationship [10] and, in order to
make readers able to fully evaluate clinical research, both
should be appropriately reported [3]. Adequate reporting
of research findings may promote the implementation of
evidence-based clinical practice in many fields, including
physical therapy [11]. However, reporting of scientific
methods receives considerably greater attention, as com-
pared with reporting of research ethics issues [12]. Many
guidelines have been published to improve the reporting
of RCTs, and adherence to these guidelines is usually
considered necessary for publication [12]. Recommenda-
tions on how ethics issues should be reported in re-
search studies are also available [13], although evidence
suggests flaws in publication requirements and reporting
of ethical protections [14]. Thus, descriptions provided
by journal articles contain little information about
research ethics methods [12].
Research reproducibility refers to the possibility to du-
plicate the results of prior studies, and is based on a clear
and comprehensive description of study design [15]. The
concept of ethical reproducibility was recently introduced.
Ethical reproducibility prescribes thorough reporting and
critical evaluation of the ethics methods employed in
biomedical research [16]. Although ethics committee
approval is a crucial aspect of ethics in research and is
usually considered as a proxy measure for the fulfillment
of all ethical requirements in research [14], it is not suffi-
cient to judge the overall ethical quality of an RCT [17].
Including ethics-related methods in research reports may
address concerns raised by researchers, clinicians, and
other stakeholders [2]. Moreover, ethical reproducibility
can promote benefits such as learning, inner reflection,
increase of ethical responsibility, critical research assess-
ment, and use of better ethical practices [12].
In the physical therapy field, interest on ethical issues
of the profession is remarkable, yet it mainly focuses on
clinical practice, whereas only few papers have been
published over the years addressing ethics in physical
therapy research [18]. Studies on issues related to ethics
in RCTs reporting were limited to ethics committee ap-
proval, informed consent, and confidentiality [14, 19].
Although stroke represents a major topic in physical
therapy research [20], none of the studies published on
ethical aspects of physical therapy research focused on
stroke. Therefore, because available knowledge does not
appear to be exhaustive and satisfactory, we designed
the present study with the aim to investigate ethics
reporting characteristics in RCTs of physical therapy
interventions after stroke.
Methods
The reporting of this study conforms to the Strengthening
the Reporting of Observational studies in Epidemiology
recommendations [21]. Based on a sample of RCTs of
physical therapy interventions after stroke, our objectives
were to investigate the reporting of multiple ethics-related
features and its variation over time, as well as the charac-
teristics of the studies associated with ethics reporting.
A random sample of RCTs indexed in PubMed was
extracted, regardless of the publication journal. To be
included, the studies had to be published in English in
the years 2004, 2009 and 2014, involve a parallel-group
design, and evaluate an experimental physical therapy
intervention administered to adult (age ≥ 18 years) indi-
viduals with stroke.
The rationale for choosing the three years was the fol-
lowing. The year 2014 had just ended when we drafted
the protocol; it was chosen to give a contemporary view.
To have a time perspective, we chose the years 2004 and
2009 as comparators, thus covering a period of ten
years.
Interventions were considered suitable if included in the
classification proposed by De Jong et al. [22], or listed in the
book “Guide to Physical Therapist Practice”[23], or reviewed
in the Clinician’s Handbooks of the Evidence-Based Review
of Stroke Rehabilitation-motor rehabilitation [24].
For the selection of the studies, the term “stroke”
followed by “physical therapy” was entered in the search
box, filtered by the type of study (RCT). Additional fil-
ters related to the year of publication (2004, 2009 and
2014) were then added one at a time to obtain a list of
studies for each of the years of interest. The resulting
search strategy was the following: ((“stroke”[MeSH
Terms] OR “stroke”[All Fields]) AND (“physical therapy
modalities”[MeSH Terms] OR (“physical”[All Fields] AND
“therapy”[All Fields] AND “modalities”[All Fields]) OR
“physical therapy modalities”[All Fields] OR (“physical”[All
Fields] AND “therapy”[All Fields]) OR “physical thera-
py”[All Fields])) AND Randomized Controlled Trial[ptyp]
AND ((“2004/01/01”[PDAT]: “2004/12/31”[PDAT]) OR
(“2009/01/01”[PDAT]: “2009/12/31”[PDAT]) OR (“2014/
01/01”[PDAT]: “2014/12/31”[PDAT])).
In each year, a random sample of the studies in the
PubMed-generated list was extracted. A formal sample
size calculation was not performed because of lack of
preliminary data; indeed, previous studies differed from
the present one in eligibility criteria, sources and
methods of studies selection, and variables of interest. In
the absence of references, to quantify the sample size we
were inspired by Pinto et al. research on RCTs registra-
tion,[25] and we established 20 % of the studies as the
target sample. We performed calculations based on the
total number of articles present in the lists, before the
screening process. The random selection was performed
in August 2015, by entering the sequence numbers of
the lists acquired through search in an on-line
randomization program [26]; the studies were then
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assessed for eligibility following the randomized sequence,
until the desired sample size was reached. Full texts of the
articles were retrieved following a flow-chart (Fig. 1).
Reasons for exclusion were given for each study ex-
cluded. Two reviewers (MV; FF) independently evaluated
the studies selected for final inclusion; disagreement was
resolved by consensus.
Relevant data were extracted using a standard data
recording spreadsheet, including characteristics of the
studies and research ethics-related issues.
Data related to year of publication, clinical trial regis-
tration, sample size, stroke subtype, phase of the disease,
setting, interventions administered, dosing of the inter-
ventions, outcome measures, and outcome of the study
were extracted from each article included. Information
about 5-year impact factor of the publishing journal was
acquired [27].
In the absence of a standardized comprehensive list,
issues related to ethics in RCTs reporting were chosen
considering what has been contemplated in previous
publications [2, 14, 17, 28]. The following aspects were
investigated in each article:
 ethics review committee or institutional review
board study approval
 details about the ethics committees
 obtainment of informed consent
 details about the consent process
 incentives or compensation for participants
 details about incentives or compensation given to
participants
 funders
 details about funders
 potential conflicts of interest
 details about conflicts of interest
 steps taken to assess if eligible individuals were able
to provide informed consent (e.g. use of validated
screening tools for cognitive ability)
 measures taken to ensure the best interests of
participants with reduced competence
 steps taken to ensure that the sample size was
sufficient to achieve adequate statistical power
 appropriateness of comparators
 justification for the eventual use of placebo
 potential harm for participants
 plans for collecting, assessing, reporting, and
managing adverse events and other unintended
effects of trial interventions or trial conduct
 appropriate follow up care
 steps taken to prevent unauthorized access to
personal and clinical data (confidentiality)
 accordance with the Helsinki Declaration.
We assumed the definition of appropriateness of com-
parator proposed by Caprino and Russo [29]; in the pres-
ence of multiple interventions groups, we considered the
Fig. 1 Full text retrieving flow chart
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most active comparator intervention. For each study in-
cluded, the number of ethics-related issues reported was
calculated by summing up any reported or mentioned
issue. The maximum achievable was 22 issues. The
extended list of questions is detailed in the Appendix.
Data were extracted from an investigator (MV) and subse-
quently double-checked (FF). Any disagreement was re-
solved by consensus. The PEDro score of methodological
quality was verified for each study [30]. This tool is reli-
able [31] and useful for assessing the quality of studies in
stroke rehabilitation [30]. Criteria for quality assessment
are represented by randomness and concealment of
allocation, baseline comparability between groups, blind-
ing of participants, therapists, and assessors, adequacy
of follow-up assessments, intention-to-treat analysis,
between-group comparisons, reporting of point esti-
mates and variability. The PEDro score ranges from 0
(poor quality) to 10 (excellent quality); a score of 6 is
conventionally considered as a threshold to identify
high-quality studies [32].
Statistical analysis
Descriptive statistics was initially performed. Five-year
impact factor equal to zero were attributed to the three
journals not found in the Journal Citation Reports data-
base [27]. In one case where only the impact factor was
available, the same value was assigned as 5-year impact
factor. Expectation-maximization imputation was used
to address missing values (2.5 and 5% respectively) of
the number of sessions per week and the minutes per
session needed to calculate the dosing of the interven-
tion in hours. Shapiro-Wilk’s test was used to test the
normality of distribution. Differences between groups
based on the year of publication were examined using
the Kruskal-Wallis or the one-way ANOVA tests for
interval variables. Pearson χ2 test was used for nominal
and ordinal variables, except when cell counts were
< 5, in which case Fisher exact test was used. Linear
trends (across years) were considered as appropriate. In
case of significant results, post-hoc tests were performed
to explore differences between any two pairs of years.
Multiple linear regression was performed to assess the
ability of year of publication, trial registration, PEDro
score, and 5-year impact factor to predict the number of
ethics-related issues reported in each article selected.
Preliminary analysis was performed to ensure there was
no violation of the assumption of normality, linearity,
and multicollinearity.
Analyses were performed using IBM SPSS Statistics
for Windows (version 20.0; IBM Corp, Armonk, NY).
The significance level was set at a p value of <.05.
Results
The search on PubMed generated lists of 57, 119, and
177 articles (total 353) for the years 2004, 2009, and
2014, respectively. The target sample size was set at 11
studies for 2004, 24 studies for 2009, and 35 studies for
2014. After randomization, a total of 162 papers were
retrieved; the selection process led to the inclusion in
the study of 80 articles (Fig. 2).
Study characteristics
Studies’ characteristics are presented in Table 1. Eighteen
percent of the selected trials had been registered. The
proportion of registered trials increased substantially
across the three years; post-hoc comparison showed that
Fig. 2 Studies selection flow chart. /*Including protocols, observational studies, preliminary reporting (e.g. recruitment or sample characteristics),
non-randomized trials, and within-subject or cross-over design studies. PT = Physical Therapy. RCT = Randomized Controlled Trial
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the probability to be not registered was greater for trials
published in the years 2004 and 2009 compared to those
published in the year 2014 (Table 2).
Median 5-year impact factor was 2.784 (1th quartile
2.130, 3rd quartile 4.626). Five-year impact factor was
greater in 2009 than in the other two years, with no
clear linear-by-linear change; post-hoc comparison
indicated that it was significantly greater in RCTs
published in the year 2009 compared to 2014
(Table 2). PEDro score ranged from 3 to 8 (median
6); there were no significant differences between years
of publication (Table 1).
Neuromuscolar interventions were most frequently
applied (53 studies), followed by musculoskeletal inter-
ventions (20 studies). Standard care was frequently used
as side intervention, or comparator (32 studies). The
outcome measures used to investigate the efficacy of the
interventions mainly belonged to muscle and movement
functions (21 studies), gait pattern functions (17 studies),
balance (13 studies), walking (9 studies), arm-hand activ-
ities (26 studies), and activities of daily living (24 studies)
of the International Classification of Functioning domains.
Ethics reporting
Ethics committee or institutional review board study
approval was reported in 65 (81.2%) studies, and 74
(92.5%) articles mentioned that consent was obtained.
Details about the ethics committee and the consent
process were available in half of the cases (51.2 and
52.5%, respectively) (Table 3). One paper failed to report
both ethics committee approval and obtainment of
informed consent (Fig. 3).
The Mini-Mental State Examination or similar test
aimed to assess cognitive capacity were administered in
the inclusion stage in 41 (51.2%) publications, namely
in 3 (23.1%), 18 (64.3%), and 20 (51.3%) studies in year
2004, 2009, and 2014, respectively; this difference
across the three years was borderline significant but









5-year Impact factora 2.967 (2.447/4.625) 4.206 (2.455/4.626) 2.179 (1.647/3.503) .011b 2.784 (2.130/4.626)
Trial registeredc 0 (0.0) 2 (7.1) 12 (30.8) .009d 14 (17.5)
Sample sizea 28 (20.0/47.0) 39 (31.5/65.0) 34 (23.0/52.5) .212b 38 (23.5/56.5)
Intervention groupsc
2 groups 11 (84.6) 21 (75.0) 34 (87.2) .418d 66 (82.5)
≥ 3 groups 2 (15.4) 7 (25.0) 5 (12.8) 14 (17.5)
Etiologyc
Ischemic 1 (7.7) 8 (28.6) 5 (12.8) 14 (17.5)
Hemorrhagic 0 (0.0) 0 (0.0) 1 (2.6) .305d 1 (1.2)
Mixed 7 (53.8) 16 (57.1) 21 (53.8) 44 (55.0)
None declared 5 (38.5) 4 (14.3) 12 (30.8) 21 (26.2)
Phase of the disease-onsetc
< 6 months 4 (30,8) 15 (53.6) 14 (35.9) 33 (41.2)
≥ 6 months 8 (61.5) 12 (42.9) 23 (59.0) .516d 43 (53.8)
None declared 1 (7.7) 1 (3.6) 2 (5.1) 4 (5.0)
Placebo-sham comparatorc 2 (15.4) 5 (17.9) 9 (23.1) .807d 16 (20.0)
Intervention dosing-hoursae 18.0 (6.0/22.5) 15.5 (11.0/27.0) 24.0 (10.0/34.7) .139b 18.0 (9.0/30.0)
At least one outcomec
Favorable 9 (69.2) 20 (71.4) 25 (64.1) .855d 54 (67.5)
Nonsignificant 11 (84.6) 25 (89.3) 36 (92.3) .614d 72 (90.0)
Unfavorable 1 (7.7) 1 (3.6) 3 (7.7) .705d 5 (6.2)
PEDro scorea 6 (5.0/6.0) 6 (5.0/7.0) 6 (5.0/7.5) .073b 6 (5.0/7.0)
a median (1th quartile/3rd quartile)
b Kruskal-Wallis test
c absolute frequencies (percentages)
d Fisher exact test
e after Expectation-maximization imputation
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had no linear-by-linear association (Table 3). In a
post-hoc test a significantly greater probability that
such assessment would not be performed was observed
for studies published in the year 2004 compared to
2009 (Table 2), Only 3 papers published in 2009
specified how consent was acquired for vulnerable
participants. Separate consents for videotaping or for
publication of participant’s photos were reported, each
in one study.
Incentives or compensation for participants (money or
gifts, or free transportation to the research center) were
stated in 3 articles published in 2014. Funders of the
studies and details related were reported in 56 (70.0%)
cases. The proportion of RCTs that declared the pres-
ence/absence of conflict of interest increased signifi-
cantly across the three years, from 23.1% (3/13) in 2004,
to 28.6% (8/28) in 2009, to 76.9% (30/39) in 2014
(Table 3). Authors declared conflict of interest only in
2 (2.5%) studies. Post-hoc comparisons showed that the
probability that potential conflict of interest and re-
lated details were not reported was greater for trials
published in the years 2004 and 2009 compared to
those published in the year 2014 (Table 2).
Statements about sample size estimation were identi-
fied in 30 (37.5%) articles, 27 of which performed a
power calculation. We considered appropriate the com-
parator interventions in 68 (85.0%) cases; participants
received the same amount of attention in 60 (75.0%)
trials, whereas in the remaining ones the attention was
minor, or the control inactive. Justification for the use of
placebo was always reported. Out of the 16 RCTs reporting
the use of placebo/sham controls, the experimental inter-
vention was represented by electrical stimulation in 10, by
acupuncture in 2, by a combination of acupuncture and
electrical stimulation in 2, by action observation train-
ing in 1, and by respiratory muscles training in 1.
Potential harm for participants was mentioned in 17
(21.2%) studies, and mainly included increased pain and/
or fatigue, risk of falls, and unstable cardiovascular
status. Plans for collecting, assessing, reporting, and
managing adverse events and other unintended effects
of trial interventions were reported respectively in 13,
11, 3, and 8 of these articles. The reporting of presence/
absence of harm or adverse events was observed in 31
(38.8%) cases (Table 3). None of the studies mentioned
eventual follow up care.
Although we found a clear reference to steps taken to
protect anonymity in only one article, confidentiality was
always preserved. Eighteen publications (30%) showed
pictures depicting models or participants: with only two
exceptions, faces were shown only in part (twice masking
the eyes region) or were shielded. As previously noted,
one study reported a specific consent for publication of
the participant’s photos.
The number of ethics-related issues reported was sig-
nificantly different across the three years considered
(one-way ANOVA F(5.07) = 6.345, p = .009) (Table 3);
Tukey post-hoc comparisons showed that this number
was significantly higher in RCTs published in the year
2014 compared to 2004, whereas there was no signifi-
cant difference between the years 2004 and 2009, and
the years 2009 and 2014 RCTs (Table 2).
Multivariable predictors of ethics reporting
Multiple regression showed that the number of
ethics-related issues reported could be predicted as
1.167 + .893* year of publication (coded as 1 = 2004, 2 =
2009, and 3 = 2014) + .799* PEDro score (F[4,75] = 11.103,
p < .001, adjusted R2 of .338). Five-year impact factor
and clinical trial registration (coded as 0 = absent and
1 = present) were not significant predictors (Table 4).
Discussion
In our study, we observed a broad variability in the
reporting proportions of ethics-related components of
Table 2 Post-hoc test results
Variable 95% CI p
Trial registrationa
2004 vs 2009 1.077 .972 to 1.193 1.000b
2004 vs 2014 1.444 1.172 to 1.781 .024b
2009 vs 2014 1.341 1.062 to 1.693 .031b
5-year impact factorc
2004 vs 2009 −.264 −1.659 to .629 .480
2004 vs 2014 .745 −.528 to 1.399 .219
2009 vs 2014 1.100 .328 to 1.842 .002
Assessment of reduced competencea
2004 vs 2009 2.154 1.207 to 3.844 .020b
2004 vs 2014 1.579 1.018 to 2.448 .110b
2009 vs 2014 .733 .405 to 1.325 .289d
Potential conflicts of interesta
2004 vs 2009 1.077 .737 to 1.573 1.000b
2004 vs 2014 3.333 1.748 to 6.358 .001b
2009 vs 2014 1.341 1.062 to 1.693 .031d
Number of ethics-related issues reportede
2004 vs 2009 −0.96 −2.98 to 1.06 .494
2004 vs 2014 −2.33 −4.26 to −0.40 .014
2009 vs 2014 −1.37 −2.86 to 0.12 .078
CI Confidence Interval
a Relative risk for the absence of the characteristic
b Fisher exact test
c Mann-Whitney test and Hodges-Lehmann estimator, data are
median differences
d Pearson χ2 test
e Tukey’s test, data are mean differences
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research methods. Ethics committee approval and
obtaining an informed consent, the main ethical issues,
were the most reported. Approximately half of the stud-
ies reported details such as name and location of the
committee, or how consent was acquired, but only 3
papers specified how consent was obtained for vulner-
able participants. Information about funding was fre-
quently reported (70% of studies), whereas that about
conflict of interest was mentioned in about half of the
studies, with a significantly increasing trend over the
years. Statement about sample size estimates, potential
harm for participants, and presence/absence of adverse
events were definitively underreported, and details about
incentives or compensation for participants and steps
taken to protect confidentiality were almost ignored.
The year of publication and PEDro score were associated
with the completeness of the reporting of ethics-related
issues.
Limitations
Articles analyzed in the present study were limited in
terms of year of publication (2004, 2009, and 2014). In
the absence of references, we established a 20 % of the
gained studies as the target sample. However, we made
Fig. 3 Ethic Committee approval and Informed Consent reporting. / Data are presented as percentages. EC = ethics review committee study
approval. IC = obtainment of informed consent
Table 3 Ethics-related issues reporting
Year 2004 (n = 13) 2009 (n = 28) 2014 (n = 39) p All studies (n = 80)
Ethic committee study approval 9 (69.2) 23 (82.1) 33 (84.6) .470b 65 (81.2)
Details about ethic committee 6 (46.2) 13 (46.4) 22 (56.4) .667c 41 (51.2)
Consent 11 (84.6) 26 (92.9) 37 (94.9) .443b 74 (92.5)
Details about the consent process 4 (30.8) 16 (57.1) 22 (56.4) .245b 42 (52.5)
Assessment of reduced cognitive competence 3 (23.1) 18 (64.3) 20 (51.3) .049b 41 (51.2)
Incentives or compensation, and details 0 (0.0) 0 (0.0) 3 (7.7) .278b 3 (3.8)
Funders and details 10 (76.9) 20 (71.4) 26 (66.7) .848b 56 (70.0)
Potential conflicts of interest 3 (23.1) 8 (28.6) 30 (76.9) <.001b 41 (51.2)
Statement about sample size estimates 5 (38.5) 8 (28.6) 17 (43.6) .455c 30 (37.5)
Performing of power calculations 5 (38.5) 7 (25.0) 15 (38.5) .478c 27 (33.8)
Appropriateness of comparators 10 (76.9) 24 (85.7) 34 (87.2) .638b 68 (85.0)
Matching of comparators 11 (84.6) 19 (67.9) 30 (76.9) .509b 60 (75.0)
Potential harm for participants 1 (7.7) 6 (21.4) 10 (25.6) .470b 17 (21.2)
Reporting presence/absence of adverse events 4 (30.8) 7 (25.0) 20 (51.3) .081b 31 (38.8)
Accordance with the Helsinki declaration. 0 (0.0) 3 (10.7) 6 (15.4) .403b 9 (11.2)
Number of ethics-related issues reporteda 7.5 (1.6) 8.5 (2.3) 9.9 (2.9) .009d 9.0 (2.6)
Data are presented as absolute frequencies (percentages) except a mean (standard deviation)
b Fisher exact test, c Pearson χ2 test, d one-way ANOVA
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our calculation based on the total number of articles
present in the PubMed-generated lists, and before the
screening process. Thus, the representativeness of our
random sample may be hypothesized higher than we
expected. We performed our search on PubMed, which
has been recognized as a comprehensive database index-
ing RCTs of physical therapy interventions [33]. To be
indexed in PubMed, journals should demonstrate one
certain quality of the editorial work, including features
such as statements indicating adherence to ethical guide-
lines and evidence that authors have disclosed financial
conflicts of interest. This condition suggests that in our
sample the reporting of ethics issues may be of better
quality than in the general population. Moreover, since
we reviewed only English-language publications, we do
not know if similar ethics reporting characteristics could
be observed in non-English language publications. These
factors limit the generalizability of the findings.
A wide range of ethical issues was considered in our
study. When we drafted the protocol, we tried to be com-
prehensive. However, establishing which ethics-related
issues should be contained in a fully comprehensive list
would require consensus from a broad multidisciplinary
expert team, which was beyond our intentions and cap-
abilities. Extracting data on the reporting of the ethical as-
pects contained in our list was challenging in the absence
of clear statements; for example, we found it difficult to
extrapolate data on issues such as those related to the
potential harm for participants. Thus, we acknowledge
that objectivity might have not been maintained in these
circumstances.
Interpretation
Associations between methodological quality and ethics
reporting practices have already been observed, [3] as
well as improvement of ethical approval and consent
reporting in RCTs [34]. Compared to a previous study
on physical therapy publications, we observed a greater
rate of trials reporting both ethics committee approval
and consent obtainment (+ 11%), as well as a smaller
rate of those who did not report either (− 16%) [14].
The reporting of research ethics-related issues and
methods observed in our sample met, to some extent, the
International Committee of Medical Journal Editors rec-
ommendations [13]. The statement underlines that details
about the approval from an ethics committee, the obtain-
ing of informed consent, and the research funding should
be reported while publishing an article. The presence of
conflict of interest is also highly emphasized, and we
notice in our sample a significant increase over time in
the related reporting. The document does not clearly for-
mulate recommendations about the ethical issues that we
found not properly reported. Nevertheless, ethics aspects
like sample size dimension and risk of harm for partici-
pants are relevant [10, 18, 35, 36]. Compensation to
participants may impact the statistical inferences, and
transparency on the topic is desirable when reporting
clinical trials [37].
Despite the progress observed, and in accordance with
other authors, [35] our findings suggest that the reporting
of many ethics-aspects needs to be improved in RCTs of
physical therapy interventions after stroke. Reporting
guidelines should be updated [35]; however, adding brief
and clear sentences to the text (e.g., “The occurrence of
adverse events has been monitored”, “No compensation
was offered to participants”, “Data were managed and
accessed only by authorized personnel”) could be a
starting point.
Conclusion
Though improved over time, ethics reporting practices in
RCTs of physical therapy interventions after stroke should
be ameliorated. With its limitations, our study shows
deficiencies of various degrees. Authors, editors, and re-
viewers should be more rigorous and demanding about
the reporting of ethic-related methods regarding the
reproducibility of research. Almost all the ethics-related
issues in our list have been recognized as part of the mini-
mum set of items to be addressed drawing a protocol for a
RCT [28]. If protocols are drawn up in accordance with
the expected standard, and subsequent trials are reported
faithfully, this should result in an increase in quantity and
quality of the ethics reporting practices in RCTs. Thus,
the understanding of ethical methods and the convergence
on best practices will be promoted, [12, 28] and a virtuous
circle originated.
Table 4 Multiple regression analysis results
B ± Std. Error 95% CI for B β t p
(Costant) 1.167 ± 1.410 −1.641 to 3.975 .828 .410
Year of publication .893 ± .368 .159 to 1.627 .251 2.424 .018
5-year Impact Factor .261 ± .164 −.066 to .589 .162 1.591 .116
Clinical trial registration .708 ± .721 −.727 to 2.144 .102 .983 .329
PEDro score .799 ± .212 .376 to 1.222 .391 3.761 <.001
B regression coefficients, followed by the respective standard error, CI confidence interval; β standardized regression coefficient
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